PYCR1 and neoplasm: Consistent with previous study in other cancer types [41, 42], our data show that silencing of PYCR1 decreases proline level to inhibit proliferation and induce apoptosis in TNBC cells, these phenotypes also contribute to PYCR1-mediated tumor growth.